These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22070019)

  • 1. [Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide].
    Adam Z; Sprláková A; Rehák Z; Koukalová R; Szturz P; Krejcí M; Pour L; Zahradová L; Cervinek L; Kren L; Moulis M; Hermanová M; Mechl M; Prásek J; Hájek R; Král Z; Mayer J
    Klin Onkol; 2011; 24(5):367-81. PubMed ID: 22070019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
    Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
    Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature].
    Adam Z; Petrášová H; Řehák Z; Koukalová R; Krejčí M; Pour L; Vetešníková E; Čermák A; Ševčíková S; Szturz P; Král Z; Mayer J
    Vnitr Lek; 2016; 62(10):820-832. PubMed ID: 27900869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PET-CT documented complete remission of Erdheim-Chester disease, lasting more than 4 years from treatment initiation with cladribine].
    Adam Z; Řehák Z; Koukalová R; Bortlíček Z; Krejčí M; Pour L; Szturz P; Prášek J; Nebeský T; Adamová Z; Král Z; Mayer J
    Vnitr Lek; 2014; 60(5-6):499, 501-11. PubMed ID: 24974755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
    Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
    Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes insipidus followed, after 4 years, with dysarthria and mild right-sided hemiparesis--the first clinical signs of Erdheim-Chester disease. Description and depiction of a case with a review of information on the disease].
    Adam Z; Balsíková K; Pour L; Krejcí M; Svacina P; Dufek M; Kren L; Hermanová M; Moulis M; Vanícek J; Neubauer J; Mechl M; Prásek J; Stanícek J; Koukalová R; Hájek R; Mayer J
    Vnitr Lek; 2009 Dec; 55(12):1173-88. PubMed ID: 20070034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review].
    Adam Z; Balsíková K; Krejcí M; Pour L; Stĕpánková S; Svacina P; Hermanová M; Vanícek J; Krupa P; Stanícek J; Koukalová R; Neubauer J; Krivanová A; Mayer J; Hájek R
    Vnitr Lek; 2010 Feb; 56(2):138-48. PubMed ID: 20329585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful treatment of Erdheim-Chester disease by 2-chlorodeoxyadenosine-based chemotherapy. Two case studies and a literature review].
    Adam Z; Koukalová R; Sprláková A; Rehák Z; Cervinek L; Szturz P; Krejcí M; Pour L; Zahradová L; Moulis M; Prásek J; Chaloupka R; Hájek R; Mayer J
    Vnitr Lek; 2011 Jun; 57(6):576-89. PubMed ID: 21751544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
    Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].
    Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J
    Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interleukin-1 receptor blockade with anakinra provided cessation of fatigue, reduction in inflammation markers and regression of retroperitoneal fibrosis in a patient with Erdheim-Chester disease - case study and a review of literature].
    Adam Z; Szturz P; Bučková P; Cervinková I; Koukalová R; Rehák Z; Krejčí M; Pour L; Zahradová L; Hájek R; Král Z; Mayer J
    Vnitr Lek; 2012 Apr; 58(4):313-8. PubMed ID: 22559807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement.
    Dion E; Graef C; Miquel A; Haroche J; Wechsler B; Amoura Z; Zeitoun D; Grenier PA; Piette JC; Laredo JD
    Radiology; 2006 Feb; 238(2):632-9. PubMed ID: 16371583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of Erdheim-Chester disease by using computerized tomography-guided stereotactic biopsy of a caudate lesion. Case report.
    Tashjian V; Doppenberg EM; Lyders E; Broaddus WC; Pavot P; Tye G; Liu AY; Perez J; Ghatak N
    J Neurosurg; 2004 Sep; 101(3):521-7. PubMed ID: 15352612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erdheim-Chester disease in a child with MR imaging showing regression of marrow changes.
    Joo CU; Go YS; Kim IH; Kim CS; Lee SY
    Skeletal Radiol; 2005 May; 34(5):299-302. PubMed ID: 15480644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erdheim-Chester disease: diffusion-weighted imaging and dynamic contrast-enhanced MRI provide useful information.
    Van Den Berghe T; Candries E; Everaert N; Saerens M; Van Dorpe J; Verstraete K
    Skeletal Radiol; 2023 Aug; 52(8):1605-1618. PubMed ID: 36602575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erdheim-Chester disease: normal skeletal radiography in a patient with extensive bone involvement].
    Gabrielli GB; Stanzial AM; Moretti L; Volpe A; Corrocher R
    Recenti Prog Med; 2005 Dec; 96(12):604-8. PubMed ID: 16496745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage lenalidomide in four rare oncological diseases.
    Szturz P; Adam Z; Rehak Z; Koukalova R; Kren L; Moulis M; Krejcí M; Mayer J
    Tumori; 2013; 99(5):e251-6. PubMed ID: 24362880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erdheim-Chester disease].
    Koziolek MJ; Kunze E; Müller A; Thiem V; Scheel AK; Müller D; Müller GA; Strutz F
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):25-8. PubMed ID: 15619170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 18FDG, 18FDOPA PET/CT and 99mTc bone scintigraphy imaging in Erdheim-Chester disease.
    García-Gómez FJ; Acevedo-Báñez I; Martínez-Castillo R; Tirado-Hospital JL; Cuenca-Cuenca JI; Pachón-Garrudo VM; Álvarez-Pérez RM; García-Jiménez R; Rivas-Infante E; García-Morillo JS; Borrego-Dorado I
    Eur J Radiol; 2015 Aug; 84(8):1586-1592. PubMed ID: 25975897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.